폴리옥시에틸렌(POE) 계열에서 두 번째로 작은 화합물인 양친매 분자 2-(2-hexyloxyethoxy) ethanol (C6E2) 수용액의 밀도를 측정하였다. 밀도 측정은 진통 튜브 밀도계를 이용하여 279.15 K와 282.15 K에서 이루어졌다. 측정된 밀도로부터 2성분 계 C6E2 (1)/H2O (2)의 과잉 부피와 부분 몰 부피를 결정하였다. 과잉 부피는 음의 편차를 나타내었으며, C6E2의 몰 분율 χ ≃ 0.45에서 최소 값을 나타내었다. C6E2 와 물 분자 사이에 끌어당기는 작용이 상대적으로 우월하지만, χ ≃ 0.45 에서 이 작용이 가장 크다는 사실을 말해준다. 2성분 계 C6E2 (1)/H2O (2)에서 부분 몰 부피 V1 는 몰 분율 χ 에 따라서 단조 증가하였으며, V2 는 감소하였다. V1 과 V2 에서 C6E2 분자들의 회합을 암시하는 특이점은 관찰되지 않았다.
A 2-year-old intact female pomeranian dog presented dyspnea, labored breathing, cough, exercise intolerance, machinery heart murmur, and precordial thrill. A left-to-right patent ductus arteriosus (PDA) was diagnosed based on two-dimensional echocardiography, thoracic radiography, electrocardiography, and blood work. An angiography was performed to accurately evaluate the size and shape of the duct. An interventional approach for transcatheterial occlusion of the PDA was achieved using an Amplatz® Canine Duct Occluder (ACDO), which is a commercially available ductal occluding device. Due to the limited size of the dog’s femoral artery, a device smaller [125% of minimal ductal diameter (MDD); recommended size: 150~200% of MDD] than recommended was mounted. After placement of the ACDO, precordial thrill and continuous heart murmur disappeared, and the patient was discharged the next day after stabilization with O2 supply. Upon follow up examination, dyspnea, labored breathing, cough, exercise intolerance, and cardiomegaly were improved with no complications after the procedure. The ACDO was well maintained in position. This case represents successful clinical application of the Amplatz® Canine Duct Occluder to achieve closure of a PDA using a slightly smaller device than the recommended size.
A 7-year-old spayed female English Cocker Spaniel dog presented with polyuria (PU), polydipsia (PD), intermittent vomiting, and weight loss. Physical examination revealed pale, tacky mucous membranes and severe emaciation. Hematological and biochemical examinations revealed moderate normocytic normochromic non-regenerative anemia and moderate azotemia. Abdominal ultrasonography demonstrated bilaterally small lumpy-bumpy kidneys with hyperechoic parenchyma as well as loss of renal corticomedullary junction. Based on clinical history and examinations, the dog was diagnosed with chronic kidney disease (CKD). The dog was treated with supportive care including fluid therapy, phosphate-binding agent, and histamine H2-receptor antagonist. Darbepoetin Alfa was administered to control renal secondary non-regenerative anemia. Prescribed diet with low-protein and low-phosphorus was fed to alleviate CKD signs. Further, dietary probiotics were supplemented. This case demonstrates that oral probiotic supplementation helped reduce blood urea-nitrogen (BUN) levels. This case indicates that dietary probiotics can be a potential alternative therapeutic agent for management of renal failure